Amprenavir is a protease inhibitor used to treat HIV infection. It was approved by
the Food and Drug Administration on April 15, 1999, for twice-a-day dosing ...
Easy to read patient leaflet for amprenavir. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Amprenavir (Agenerase - discontinued brand) is a drug prescribed to treat
infections with HIV. Side effects, drug interactions, and pregnancy safety
information is ...
Jul 16, 2008 ... Learn about Agenerase Capsules (Amprenavir Capsules) may treat, uses,
dosage, side effects, drug interactions, warnings, patient labeling, ...
Jan 25, 2001 ... Approval. Amprenavir was approved by the U.S. Food and Drug Administration (
FDA) in 1999 for use in adults and children with HIV infection.
Agenerase (amprenavir): For the treatment of HIV-1 infection.. New approved
drug details including side effects, uses and general information.
Amprenavir is an human immunodeficiency virus (HIV) protease inhibitor with
IC50 of 14.6 ± 12.5 ng/ml for wild-type HIV isolates. Order Amprenavir (
Manufacture of amprenavir was discontinued in October 2007. It is being
replaced by fosamprenavir (see fact sheet 448). Fosamprenavir is a pro-drug of ...
1T7J: Discovery and selection of TMC114, a next generation HIV-1 protease
Sigma-Aldrich offers Sigma-SML0685, Amprenavir for your research needs. Find
product specific information including CAS, MSDS, protocols and references.